Under the incisive audit of Aisling Chin-Yee, this asset supplies a provocative autopsy of healthcare inequality. The narrative dismantles the corporate barriers surrounding female pleasure to inject a vital discourse on bodily autonomy. It is a supply of documentary p r e s t i g i o that processes the friction between scientific progress and patriarchal gatekeeping. Through a series of high-stakes investigations, the film audits the pharmaceutical industry, forcing the spectator to process a reality where the control of desire is the final frontier of equality.
